FDA issues first draft guidance on use of AI in drug, medical device development

Recognizing the increased use of artificial intelligence in the development of new therapies, the U.S. FDA on Monday released separate draft guidance on the use of the technology in the development of new drugs and medical devices.

For drugs, the guidance